Maple Telehealth GLP-1

Maple is Canada's largest telehealth platform, connecting millions of Canadians with licensed healthcare providers across all provinces and territories. The platform offers GLP-1 prescriptions including Ozempic (for type 2 diabetes) and Wegovy (for weight management) through online consultations with Canadian board-certified physicians. Maple is known for its speed — patients can often connect with a physician within minutes for consultations, with prescription turnaround typically within a few hours. The platform accepts most provincial health cards for the consultation component, though GLP-1 medications themselves are not covered by provincial drug plans for weight loss as of January 2026. Patients pay out-of-pocket for medication or through their private insurance plan. Ozempic costs approximately CAD $200-$300/month and Wegovy runs higher. Maple operates across all 13 Canadian provinces and territories and has served over three million Canadians since 2015. The platform also provides a blog and patient education resources covering the Canadian GLP-1 landscape.